Suppr超能文献

在HL-60、U937和Jurkat细胞中,类黄酮通过阻断脱氢抗坏血酸和抗坏血酸的摄取来抑制抗坏血酸的细胞内积累。

Intracellular accumulation of ascorbic acid is inhibited by flavonoids via blocking of dehydroascorbic acid and ascorbic acid uptakes in HL-60, U937 and Jurkat cells.

作者信息

Park J B, Levine M

机构信息

Phytonutrients Laboratory, BHNRC, ARS, U.S. Department of Agriculture, Beltsville 20705, USA.

出版信息

J Nutr. 2000 May;130(5):1297-302. doi: 10.1093/jn/130.5.1297.

Abstract

In HL-60, U937 and Jurkat cells, the intracellular accumulation of ascorbic acid occurred via uptakes of both dehydroascorbic acid (an oxidized metabolite of ascorbic acid) and ascorbic acid (vitamin C). Dehydroascorbic acid and ascorbic acid were transported into cells by sodium-independent glucose transporters (GLUT 1 and GLUT 3) and sodium-dependent ascorbic acid transporters, respectively. Flavonoids inhibited the intracellular accumulation of ascorbic acid by blocking dehydroascorbic acid and ascorbic acid uptakes in the transformed cells. At flavonoid concentrations of 10-70 micromol/L, approximately 50% of dehydroascorbic acid uptake was inhibited in the cells. In Jurkat cells, two potent flavonoids (myricetin and quercetin) competitively inhibited dehydroascorbic acid uptake, and K(i) values were approximately 14 and 15 micromol/L, respectively. Because GLUT 1 and GLUT 3 transport dehydroascorbic acid, the inhibition of dehydroascorbic acid uptake by flavonoids was investigated by using Chinese hamster ovary cells overexpressing rat GLUT 1 or human GLUT 3. Myricetin at concentrations of 22 and 18 micromol/L, respectively, inhibited half of dehydroascorbic acid uptake in the cells overexpressing GLUT 1 and GLUT 3. Myricetin also inhibited ascorbic acid uptake; inhibition was noncompetitive with K(i) = 14 micromol/L in Jurkat cells. These data indicate that flavonoids inhibit both ascorbic acid and dehydroascorbic acid uptake but do so by different mechanisms. These data may contribute to new understanding of the biological effect of flavonoids on the intracellular accumulation of ascorbic acid in human cells.

摘要

在HL-60、U937和Jurkat细胞中,抗坏血酸的细胞内积累是通过脱氢抗坏血酸(抗坏血酸的一种氧化代谢物)和抗坏血酸(维生素C)的摄取实现的。脱氢抗坏血酸和抗坏血酸分别通过不依赖钠的葡萄糖转运蛋白(GLUT 1和GLUT 3)和依赖钠的抗坏血酸转运蛋白转运进入细胞。黄酮类化合物通过阻断转化细胞中脱氢抗坏血酸和抗坏血酸的摄取来抑制抗坏血酸的细胞内积累。在黄酮类化合物浓度为10 - 70微摩尔/升时,细胞中约50%的脱氢抗坏血酸摄取受到抑制。在Jurkat细胞中,两种强效黄酮类化合物(杨梅素和槲皮素)竞争性抑制脱氢抗坏血酸摄取,其抑制常数(K(i))值分别约为14和15微摩尔/升。由于GLUT 1和GLUT 3转运脱氢抗坏血酸,因此利用过表达大鼠GLUT 1或人GLUT 3的中国仓鼠卵巢细胞研究了黄酮类化合物对脱氢抗坏血酸摄取的抑制作用。杨梅素浓度分别为22和18微摩尔/升时,分别抑制了过表达GLUT 1和GLUT 3的细胞中一半的脱氢抗坏血酸摄取。杨梅素也抑制抗坏血酸摄取;在Jurkat细胞中,抑制作用为非竞争性,K(i) = 14微摩尔/升。这些数据表明,黄酮类化合物抑制抗坏血酸和脱氢抗坏血酸的摄取,但作用机制不同。这些数据可能有助于重新认识黄酮类化合物对人细胞内抗坏血酸积累的生物学效应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验